未知生产厂商
AGI-1096 is a novel oral antioxidant and selective anti-inflammatory agent that is being developed to address the accelerated inflammation of grafted blood vessels, known as transplant arteritis, common in chronic organ transplant rejection.
AGI-1096 is a novel oral antioxidant and selective anti-inflammatory agent that is being developed to address the accelerated inflammation of grafted blood vessels, known as transplant arteritis, common in chronic organ transplant rejection.
AGI-1096 is a novel phenolic intracellular antioxidant with anti-inflammatory and antiproliferative properties.
Investigated for use/treatment in transplant (rejection).
